share_log

Chemed Insiders Sold US$23m Of Shares Suggesting Hesitancy

Chemed Insiders Sold US$23m Of Shares Suggesting Hesitancy

Chemed Insiders出售了2300万美元的股票,这表明他们犹豫不决
Simply Wall St ·  02/02 08:49

In the last year, many Chemed Corporation (NYSE:CHE) insiders sold a substantial stake in the company which may have sparked shareholders' attention. When evaluating insider transactions, knowing whether insiders are buying versus if they selling is usually more beneficial, as the latter can be open to many interpretations. However, when multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag.

去年,许多Chemed Corporation(纽约证券交易所代码:CHE)内部人士出售了该公司的大量股份,这可能引起了股东的关注。在评估内幕交易时,了解内部人士是买入还是卖出通常更有利,因为后者可能有多种解释。但是,当多个内部人士在特定期限内出售股票时,股东应注意,因为这可能是一个危险信号。

While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.

尽管在长期投资方面,内幕交易并不是最重要的事情,但我们确实认为密切关注内部人士的所作所为是完全合乎逻辑的。

Chemed Insider Transactions Over The Last Year

去年的Chemed内幕交易

Over the last year, we can see that the biggest insider sale was by the insider, David Williams, for US$3.5m worth of shares, at about US$584 per share. That means that an insider was selling shares at slightly below the current price (US$598). We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. While insider selling is not a positive sign, we can't be sure if it does mean insiders think the shares are fully valued, so it's only a weak sign. We note that the biggest single sale was only 27% of David Williams's holding.

在过去的一年中,我们可以看到,最大的内幕出售是知情人大卫·威廉姆斯以每股约584美元的价格出售了价值350万美元的股票。这意味着一位内部人士正在以略低于当前价格(598美元)的价格出售股票。如果内部人士一直在卖出,特别是如果他们卖出低于当前价格,我们通常认为这是负面的,因为这意味着他们认为较低的价格是合理的。尽管内幕抛售不是一个积极的信号,但我们无法确定这是否意味着内部人士认为股票已完全估值,因此这只是一个弱势信号。我们注意到,最大的单笔交易仅占大卫·威廉姆斯持股量的27%。

In the last year Chemed insiders didn't buy any company stock. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

去年,Chemed内部人士没有购买任何公司股票。下图显示了去年的内幕交易(公司和个人)。如果你想确切地知道谁卖了、卖了多少以及何时出售,只需点击下图!

insider-trading-volume
NYSE:CHE Insider Trading Volume February 2nd 2024
纽约证券交易所:CHE 内幕交易量 2024 年 2 月 2 日

I will like Chemed better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我看到一些重大的内幕收购,我会更喜欢Chemed。在我们等待的同时,请查看这份免费清单,列出了最近有大量内幕收购的成长型公司。

Chemed Insiders Are Selling The Stock

Chemed Insiders 正在出售这只股票

The last quarter saw substantial insider selling of Chemed shares. In total, insiders sold US$11m worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain.

上个季度,Chemed股票出现了大量内幕抛售。在此期间,内部人士总共出售了价值1100万美元的股票,我们没有记录任何购买记录。有鉴于此,很难说所有内部人士都认为股票很划算。

Insider Ownership Of Chemed

Chemed 的内部所有权

Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. Chemed insiders own 1.9% of the company, currently worth about US$173m based on the recent share price. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

许多投资者喜欢检查一家公司有多少股份由内部人士拥有。我们通常希望看到相当高的内部所有权水平。Chemed内部人士拥有该公司1.9%的股份,根据最近的股价,目前价值约1.73亿美元。我喜欢看到这种程度的内部所有权,因为它增加了管理层考虑股东最大利益的机会。

So What Do The Chemed Insider Transactions Indicate?

那么,Chemed的内幕交易表明了什么?

Insiders haven't bought Chemed stock in the last three months, but there was some selling. And there weren't any purchases to give us comfort, over the last year. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Chemed. While conducting our analysis, we found that Chemed has 1 warning sign and it would be unwise to ignore this.

内部人士在过去三个月中没有买入Chemed的股票,但出现了一些抛售。在过去的一年里,没有任何能让我们感到安慰的购买。该公司拥有很高的内部所有权,但考虑到股票销售的历史,我们有点犹豫。除了了解正在进行的内幕交易外,确定Chemed面临的风险也是有益的。在进行分析时,我们发现Chemed有1个警告信号,忽略这一点是不明智的。

But note: Chemed may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

但请注意:Chemed可能不是最值得购买的股票。因此,来看看这份投资回报率高、债务低的有趣公司的免费清单。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,内部人士是指向相关监管机构报告其交易的个人。我们目前只考虑公开市场交易和私下处置的直接利益,不包括衍生品交易或间接权益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发